Get our latest issue now

available for iOS, Android & web

latest issue

Editor's letter

It has been a busy month in the world of pharmaceuticals; a clinical trial went badly wrong resulting in the tragic death of one participant, regulators gave the green light to the first biosimilar of Pfizer/Amgen’s Enbrel and, here in the UK, the health minister squared up for a fight with junior doctors – again. We cover these and all the other top stories in our News Review.

Here at PharmaTimes we learned a lot this month. In Shock Therapy (p26) we discovered that cheap nerve stimulators could replace blockbuster drugs in the treatment of severe inflammatory conditions including rheumatoid arthritis and irritable bowel syndrome. We also found out that while the majority of healthcare professionals favour the disclosure of payments made by pharma companies, a debate is raging in the industry about what this new level of transparency will look like. Read about it in An Open Relationship (p31).

Plus, our ever-opinionated SmartViews section taught us a few lessons. In A Problem Shared? (p15) KPMG advisor Sophia Turner makes the case for companies sharing their preclinical data in order to boost R&D productivity, while regular contributor Ana Nicholls from the Economist Intelligence Unit looks ahead at the year to come in A Bumpy Road Ahead (p20).

In our interview-based SmartPeople section, we tell three important stories; lupus patient and advocate Sally Kay (p41) talks about her personal experience with the disease, Mark Samuels from the National Institute for Health Research predicts great things ahead for UK R&D (p34) and Creston Health head Nicky Walsby tells pharma it needs to think outside the box if it wants to connect to the consumer (p36).

I hope you enjoy this issue of PharmaTimes and, as always, if you have any thoughts or opinions do get in touch at

Hugh Gosling


To read the latest issue of PharmaTimes Magazine, sign up for a free digital subscription or download our free app via iTunes or Google play. 

 app store

google play

About PharmaTimes Magazine

PharmaTimes Magazine print and digital versions have a total circulation of 23,184, including 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.

PharmaTimes Magazine delivers independent, authoritative and trustworthy content on healthcare issues and topics, through impartial coverage in print and online. It brings together key stakeholders through a strong readership, including pharma and the NHS, by providing balanced and informed opinion and analysis around the key issues, trends and developments affecting today’s fast-moving environment.

PharmaTimes Online News Archive offers unique access to past issues of PharmaTimes Magazine and news elert stories.

©PharmaTimes Magazine 2015. All rights reserved. Material prepared by PharmaTimes Magazine is prohibited for use by third parties and publishers without permission.

Find a job

Website Search

Search News Search Magazine

Business Insight

Zenopa Business Insight

Competitions News


International Clinical Researcher of the Year 2016

Book your tickets today!

Elert Signup!